The Hawaii House Health Committee approved SB 3199, a bill to create a Mental Health Emerging Therapies Task Force to study and recommend policies for the therapeutic use of psychedelics like psilocybin and MDMA. The task force, led by the University of Hawaii’s medical school, will spend two years reviewing research to prepare the state for potential federal rescheduling of these substances.

Hawaii Lawmakers Move One Step Closer to Setting Up Psychedelics Task Force

Mar 24, 2026

Source:

Tom Angell

Marijuana Moment

Hawaii is taking a major step toward expanding its therapeutic horizons as a House committee recently greenlit a bill to establish a psychedelics task force. Already approved by the Senate, SB 3199 aims to create a dedicated group under the University of Hawaii’s medical school to study the medical potential of substances like psilocybin and MDMA. The goal is to spend two years crafting a safe, culturally respectful framework for these "breakthrough therapies," preparing the state for inevitable federal rescheduling. While traditional cannabis legalization has stalled this session, this move shows Hawaii is serious about tackling mental health crises for veterans and trauma survivors.

For the local community, this is a huge win for progress and accessibility. It proves that lawmakers are finally listening to the science and looking for real solutions beyond outdated stigmas. While we wait for recreational cannabis to catch up, the push for regulated psychedelic access keeps the momentum for cognitive liberty moving forward in the Islands.